StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note released on Sunday. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens raised their target price on shares of Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, January 31st.
Veradigm Stock Performance
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- How to Use Stock Screeners to Find Stocks
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- How to Start Investing in Real Estate
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Energy and Oil Stocks Explained
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
